Transcription:

Overview of Genetic Information Flow

  • Discussion of the process of transcription and RNA processing.

  • Importance of understanding the flow of genetic information from DNA to phenotype.

  • Proteome:

    • Defined as the entire set of proteins expressed by a genome.

    • Proteome offers more possibilities than the human genome.

    • Same gene can produce multiple gene products due to alternative splicing (indicated by blue arrows).

    • Interaction of gene products creates diverse cellular functions.

    • Example: DMD gene associated with Duchenne muscular dystrophy.

Gene Expression

  • Gene Products:

    • Proteins that come from genes are central to function and phenotype.

    • 20,000 coding genes can lead to numerous phenotypic outcomes due to various expressions and interactions.

    • Genes can exist in multiple copies affecting gene expression levels.

    • Pseudogenes resemble functional genes but may not produce effective products.

Non-Coding RNAs (ncRNAs)

  • Approximately half of the genome is thought to encode for ncRNAs, which can impact gene expression.

    • Examples of ncRNAs include:

    • tRNAs (transfer RNAs)

    • mRNAs (messenger RNAs)

    • microRNAs.

  • rnAs can influence gene expression and protein functionality.

The Central Dogma of Molecular Biology

  • Definition: The central dogma establishes the framework for understanding genetic information flow:

    • DNA → RNA → Protein

    • A key focus is on transcription (DNA to RNA), while DNA replication is a separate process previously covered.

  • Location of Processes:

    • Transcription: Occurs in the nucleus.

    • Translation: Occurs in ribosomes in the cytoplasm.

  • The relationship delineates how nucleic acid sequences are translated into amino acid sequences of proteins.

Transcription Process

  • Essential components for transcription include:

    • Template DNA: Double-stranded genomic DNA.

    • Raw Materials: RNA nucleotide bases for the new RNA strand.

    • Transcription Machinery: Enzymes and proteins necessary to synthesize RNA.

Structure of DNA and Genes

  • The double-stranded nature of DNA involves complementary base pairing:

    • Guanine (G) with Cytosine (C)

    • Adenine (A) with Thymine (T).

  • A gene's structure includes:

    • Promoter: A sequence determining when a gene is expressed.

    • Exons: Coding sequences that are part of the final mRNA.

    • Introns: Non-coding sequences that are removed during RNA processing.

    • Untranslated Regions (UTRs): Non-coding sections at the 5' and 3' ends.

    • Poly A Tail: Added to the 3' end for stability and export from the nucleus.

  • Transcription Direction: RNA synthesis runs from 5' to 3' on the mRNA strand, using 3' to 5' on the DNA template strand.

Transcription Elaboration

  • RNA Polymerase II: Binds to the promoter to initiate transcription by separating DNA strands and synthesizing RNA.

    • The presence of CpG islands helps in the binding of transcription factors to promoters.

    • Specific sequences known as cat boxes and TATA boxes indicate important regulatory sites for transcription initiation.

  • Elongation Phase: RNA polymerase synthesizes mRNA by adding nucleotides complementary to the DNA template.

  • Termination Phase: Differentiates where transcription terminates upon encountering a specific sequence.

Differences Between DNA and RNA

  • Main distinctions include:

    • Strands: DNA is double-stranded; RNA is single-stranded.

    • Sugar: DNA contains deoxyribose, while RNA contains ribose.

    • Bases: Thymine (T) in DNA is replaced by Uracil (U) in RNA.

RNA Processing Following Transcription

  • Occurs in the nucleus where several modifications take place:

    • Intron Removal: Enzymatic splicing of introns to create mature mRNA candidates.

    • Spliceosome Complex: Recognizes splice sites using specific sequences (GT at the beginning of introns; AG at the end).

  • Alternative Splicing:

    • Mechanism enabling a single gene to produce multiple mRNA variants, enhancing protein diversity.

    • Different exons may be included or excluded, such as in the example of protein production where an exon might be skipped.

Real-Life Example: Human Beta Globin Gene (HBV)

  • Examines how the nucleotide sequence is structured:

    • Exons (tan shaded areas) correspond to expressed sequences in mRNA.

    • Introns and relevant DNA structures (e.g., TATA box) denoted.

    • Important junctions highlighted by dinucleotide sequences important for the spliceosome action.

Conclusion of RNA Processing

  • Addition of the 5' Cap: A modified guanine added to prevent degradation and facilitate ribosome binding.

  • Poly A Tail Addition: Facilitates mRNA stability, composed of adenine nucleotides.

    • Amount and length of the poly A tail are variable and can influence translational efficiency.

  • Both transcription and processing functions occur in the nucleus, ultimately allowing mature mRNA to exit to the cytoplasm for translation into proteins.

Future Focus

  • Next lectures will delve into translation, culminating the central dogma's exploration of gene expression.


Overview of Genetic Information Flow
  • Genetic Flow and Phenotype: The primary pathway of biological information moves from DNA to RNA to Proteins. This flow determines the phenotype of an organism by regulating which proteins are produced, in what quantity, and at what time.

  • The Proteome:

    • Definition: The entire set of proteins expressed by a genome, cell, tissue, or organism at a given time.

    • Complexity: The human proteome is significantly more complex than the genome (∼20,000\sim 20,000 genes vs. over 1,000,0001,000,000 protein variants). This discrepancy is due to post-transcriptional and post-translational modifications.

    • Alternative Splicing: A regulated process during gene expression that results in a single gene coding for multiple proteins. Differential inclusion/exclusion of exons allows for functional diversity.

    • Example: The DMD (Dystrophin) gene, one of the largest known human genes, undergoes extensive splicing; mutations here often lead to Duchenne muscular dystrophy.

Gene Expression and Regulation
  • Gene Products: Functional units (mostly proteins, but also ncRNAs) that execute cellular tasks.

  • Copy Number Variation (CNV): Genes can exist in multiple copies within a genome, which can proportionally increase the amount of mRNA and protein produced, influencing the phenotype.

  • Pseudogenes: Genomic DNA sequences that are similar to normal genes but have accumulated mutations (e.g., premature stop codons) that render them non-functional. Some can still be transcribed into ncRNAs that regulate their functional counterparts.

Non-Coding RNAs (ncRNAs)
  • Prevalence: Modern transcriptomics suggests that while only 2%2\% of the genome codes for proteins, up to 70−80%70-80\% may be transcribed into ncRNAs.

  • Key Classes of ncRNAs:

    • tRNAs (Transfer RNAs): Adaptor molecules that decipher the genetic code during translation.

    • mRNAs (Messenger RNAs): The intermediates carrying the genetic blueprint from the nucleus to the ribosome.

    • microRNAs (miRNAs): Small RNAs (∼22\sim 22 nucleotides) that bind to complementary sequences on target mRNAs to repress translation or trigger degradation.

    • snRNAs (Small Nuclear RNAs): Essential components of the spliceosome that catalyze the removal of introns.

The Central Dogma of Molecular Biology
  • Framework: Established by Francis Crick, it describes the sequential transfer of information: DNA→RNA→ProteinDNA \rightarrow RNA \rightarrow Protein.

  • Exceptions: Reverse transcriptase (found in retroviruses) allows for information flow from RNA→DNARNA \rightarrow DNA, and prions involve protein-to-protein information transfer.

  • Compartmentalization:

    • Transcription: Occurs within the nucleus where DNA is protected.

    • Translation: Occurs on ribosomes in the cytoplasm or on the Rough Endoplasmic Reticulum (RER).

Transcription Process: Detailed Mechanism
  • Essential Components:

    • Template DNA: Only the "antisense" strand (3′→5′3' \to 5') is used as a template for RNA synthesis.

    • Substrates: Ribonucleoside triphosphates (rNTPsrNTPs: ATP, CTP, GTP, UTP).

    • RNA Polymerase II: The main enzyme responsible for transcribing protein-coding genes.

DNA and Gene Regulatory Elements
  • Promoter Region: Located upstream (5′5') of the start site.

    • TATA Box: A consensus sequence (5′−TATAAA−3′5'-TATAAA-3') that helps position RNA Polymerase II.

    • CpG Islands: Regions with a high frequency of cytosine-guanine dinucleotide pairs, often targets for DNA methylation to silence gene expression.

  • Exons vs. Introns:

    • Exons: Expressed sequences that remain in the mature mRNA.

    • Introns: Intervening sequences that are excised. They often contain regulatory elements like enhancers or silencers.

  • UTRs (Untranslated Regions): Found at the 5′5' and 3′3' ends of exons; they are vital for mRNA stability and translational efficiency.

Phases of Transcription
  1. Initiation: General transcription factors (GTFs) bind to the promoter, recruiting RNA Polymerase II to form the Transcription Initiation Complex.

  2. Elongation: RNA Polymerase moves along the template strand in the 3′→5′3' \to 5' direction, synthesizing a complementary RNA strand in the 5′→3′5' \to 3' direction.

  3. Termination: Transcription continues until a termination signal is reached. In eukaryotes, this is often linked to the polyadenylation signal (AAUAAAAAUAAA).

Biochemical Differences: DNA vs. RNA
  • Strand Geometry: DNA is typically a stable B-form double helix; RNA is single-stranded but often folds into complex secondary structures (hairpins, loops).

  • Pentose Sugar: DNA uses 2′-deoxyribose2'\text{-deoxyribose} (missing an oxygen at the 2′2' position), making it more chemically stable. RNA uses ribose, which has a 2′-OH2'\text{-OH} group.

  • Nitrogenous Bases:

    • DNA: Adenine (AA), Thymine (TT), Guanine (GG), Cytosine (CC).

    • RNA: Adenine (AA), Uracil (UU), Guanine (GG), Cytosine (CC). Uracil lacks the methyl group found in Thymine.

Post-Transcriptional RNA Processing
  • 5' Capping: A modified guanine nucleotide (7-methylguanosine7\text{-methylguanosine}) is added via a unique 5′ to 5′5' \text{ to } 5' triphosphate bridge. This protects the mRNA from exonucleases and assists in ribosome recruitment.

  • RNA Splicing:

    • Spliceosome: A large complex of snRNPs (small nuclear ribonucleoproteins).

    • Splicing Signals: Splicing occurs at specific conserved sequences: GUGU at the 5′5' splice site (donor) and AGAG at the 3′3' splice site (acceptor).

  • Alternative Splicing Variations: Includes exon skipping, intron retention, and alternative site selection, allowing for tissue-specific protein isoforms.

  • 3' Polyadenylation: An enzyme (Poly-A Polymerase) adds 50−25050-250 adenine nucleotides to the 3′3' end. This "Poly-A tail" is crucial for nuclear export, stability, and translation.

Case Study: Human Beta Globin (HBB)
  • The HBB gene consists of three exons and two introns. Mutations in the splice sites (the GT/AGGT/AG junctions) can lead to improper splicing, resulting in Beta-thalassemia, a blood disorder characterized by reduced hemoglobin production.

Conclusion and Transition to Translation
  • Once processing is complete, the "mature mRNA" is exported through nuclear pore complexes. The next phase, translation, involves the conversion of the mRNA nucleotide sequence into a polypeptide chain using the universal genetic code.